Fu Nini, Li Hang, Sun Jingchang, Xun Liying, Gao Dongmei, Zhao Qitao
School of Pharmaceutical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, China.
School of Basic Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Front Physiol. 2018 Jan 17;8:1132. doi: 10.3389/fphys.2017.01132. eCollection 2017.
(TP) had been widely used to cure patients of cardiovascular disease for 2,000 years in China. This study aims to extend our previous work to explore the mechanism underlying the protective effect of TP on acute myocardial ischemia (AMI). We hypothesized that TP may display its protective effect on AMI by promoting the mobilization of endothelial progenitor cells (EPC) via up-regulating the expression level of vascular endothelial growth factor (VEGF), endothelial nitric oxide syntheses (eNOS), nitric oxide (NO), and matrix metalloproteinase 9 (MMP-9) in AMI rats. To confirm this hypothesis, we treated AMI model rats with intragastrical administration of TP aqueous extract (TPAE), and examined both changes in the number of CEPC, and the expression levels of VEGF, eNOS, NO, and MMP-9 in myocardial tissue and their plasma content in these rats. Rats in each group were randomly divided into seven subgroups. From day 1 to 7 following AMI modeling, rats in these subgroups was sequentially phlebotomized from their celiac artery after being anesthetized by chloral hydrate. We found that, compared with the AMI model rats, in rats treated by TPAE, the CEPC counts, the expression of VEGF, eNOS, NO, and MMP-9 in myocardial tissue and their plasma content all increased more rapidly 7 days after AMI and remained at higher level ( < 0.05 or < 0.01). Our results showed that, in AMI rats, the TPAE could significantly promote the mobilization of EPC and up-regulate the expression level of VEGF, eNOS, NO, and MMP-9 in myocardium and their plasma content. Therefore, our results suggest that TAPE may regulate EPC mobilization through up-regulating the expression level of VEGF, eNOS, NO and MMP-9 in the myocardium of AMI rats.
在中国,丹参酮(TP)已被广泛用于治疗心血管疾病患者达2000年之久。本研究旨在扩展我们之前的工作,以探究TP对急性心肌缺血(AMI)保护作用的潜在机制。我们假设TP可能通过上调AMI大鼠血管内皮生长因子(VEGF)、内皮型一氧化氮合酶(eNOS)、一氧化氮(NO)和基质金属蛋白酶9(MMP-9)的表达水平,促进内皮祖细胞(EPC)的动员,从而对AMI发挥保护作用。为证实这一假设,我们对AMI模型大鼠进行胃内给予丹参酮水提取物(TPAE)处理,并检测这些大鼠循环血中EPC数量的变化以及心肌组织中VEGF、eNOS、NO和MMP-9的表达水平及其血浆含量。每组大鼠随机分为七个亚组。在AMI建模后的第1天至第7天,这些亚组的大鼠在经水合氯醛麻醉后,依次从其腹腔动脉取血。我们发现,与AMI模型大鼠相比,TPAE处理的大鼠在AMI后7天,循环血中EPC计数、心肌组织中VEGF、eNOS、NO和MMP-9的表达及其血浆含量均升高得更快,且维持在较高水平(P<0.05或P<0.01)。我们的结果表明,在AMI大鼠中,TPAE可显著促进EPC的动员,并上调心肌中VEGF、eNOS、NO和MMP-9的表达水平及其血浆含量。因此,我们的结果提示,TPAE可能通过上调AMI大鼠心肌中VEGF、eNOS、NO和MMP-9的表达水平来调节EPC的动员。